Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;38(8):1677-84.
doi: 10.1007/s00264-014-2376-0. Epub 2014 May 29.

Incidence and management of hip dislocation in tumour patients with a modular prosthesis of the proximal femur

Affiliations

Incidence and management of hip dislocation in tumour patients with a modular prosthesis of the proximal femur

Stephan E Puchner et al. Int Orthop. 2014 Aug.

Abstract

Purpose: Little data is available about the incidence and especially the management of hip dislocation following the implantation of modular tumor prostheses of the proximal femur. In this retrospective single-centre study we assessed the incidence of hip dislocation following implantation of a proximal femoral modular prosthesis as well as the success of the subsequent surgical or non-surgical treatment in tumor patients.

Methods: Between 1982 and 2008, 166 tumor patients received a modular prosthesis of the proximal femur at our institution. The average age at the time of surgery was 50 ± 20 years (range, six to 84 years). An additional pelvic reconstruction was done in 14 patients. An artificial band for soft tissue reconstruction of the hip was used in 19 patients. The average time of follow-up was 46 ± 64 months (range, one to 277 months).

Results: The overall dislocation rate after proximal femoral replacement was 13% after a mean time of seven ± eight months (range, 0.3-33 months) after surgery. Between 1982 and 1986 the dislocation rate was 33% and declined to 9% in subsequent years (1987-2008). Patients who had received an additional pelvic reconstruction had a three fold higher dislocation rate (p <0.05). Patients with closed reduction had a 58% (eight of 12) re-dislocation rate compared to 11% (one of nine) for open reduction (p = 0.0357).

Conclusions: Dislocation of a modular prosthesis of the proximal femur is a common complication, especially in cases with additional pelvic resection with extensive bone and soft-tissue defects. Open surgical management may be more effective in preventing re-dislocation than closed reduction and bracing alone.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The Kaplan-Meier survival analysis shows the overall survival of all patients (65 % at one year, 30 % at five years and 25 % at ten years)
Fig. 2
Fig. 2
The Kaplan-Meier survival analysis shows the implant survival rate until first dislocation (88 % at one year and 83 % at five years)
Fig. 3
Fig. 3
Flowchart illustrating dislocation rates and success rates after subsequent treatment of proximal femoral replacements with and without pelvic reconstruction
Fig. 4
Fig. 4
Radiological imaging of a 64-year-old male patient with history of renal cell carcinoma and bone metastasis to the right proximal femur and acetabulum with pathological subtrochanteric fracture. The patient underwent resection of the proximal femur and extended curettage of the acetabular defect. Reconstruction was performed by a modular endoprosthesis of the proximal femur (GMRS®, Stryker Corp, Mahwah, NJ) and a pedestal cup (Schoellner cup, Zimmer, Warsaw, IN). The patient suffered dislocation three months after surgery and was treated by closed reduction and bracing for six weeks without further dislocation until death of disease. a AP radiograph of the proximal femur preoperative. b Frontal plain MRI of the lesion. c and d Postoperative AP radiograph. e AP radiograph of the dislocated prosthesis. f AP radiograph after closed reduction and bracing

References

    1. Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu AT, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009;91:108–112. doi: 10.1302/0301-620X.91B1.20448. - DOI - PubMed
    1. Kotz RI. Progress in musculoskeletal oncology from 1922–2012. Int Orthop. 2014;38:1113–1122. doi: 10.1007/s00264-014-2315-0. - DOI - PMC - PubMed
    1. Tunn PU, Pomraenke D, Goerling U, Hohenberger P. Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours–a comparative analysis using the MSTS score, the TESS and the RNL index. Int Orthop. 2008;32:619–625. doi: 10.1007/s00264-007-0388-8. - DOI - PMC - PubMed
    1. Kabukcuoglu Y, Grimer RJ, Tillman RM, Carter SR (1999) Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res 358:8–14 - PubMed
    1. Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res. 2006;450:164–171. doi: 10.1097/01.blo.0000223978.36831.39. - DOI - PubMed

MeSH terms

LinkOut - more resources